Vsee Health (VSEEW) Income from Non-Controlling Interests (2023 - 2024)
Vsee Health (VSEEW) reported Income from Non-Controlling Interests of $31980.0 for Q1 2024, up 770.86% on a YoY basis from $3672.2 in Q2 2023, and down 5.24% quarter-over-quarter from $33749.0 in Q4 2023.
Vsee Health (VSEEW) Income from Non-Controlling Interests (2023 - 2024) Analysis & Trends
Vsee Health has reported Income from Non-Controlling Interests for 2 years, with the latest figure at $31980.0 in Q1 2024.
- For the quarter ending Q1 2024, Income from Non-Controlling Interests rose 770.86% year-over-year to $31980.0; the trailing twelve-month figure through Jun 2025 stood at $65729.0 (changed N/A YoY), and the FY2023 full-year result was $37476.0, changed N/A from the prior year.
- Income from Non-Controlling Interests for Q1 2024 stood at $31980.0, down from $33749.0 in the prior quarter.
- The five-year high for Income from Non-Controlling Interests was $33749.0 in Q4 2023, with the low at -$4767.0 in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 26.11 Bn | 18.79 Bn | 662.02 Mn | - |
| 2 | BrightSpring Health Services | 12.95 Bn | 12.07 Bn | 482.22 Mn | -157,000.00 |
| 3 | Healthequity | 7.46 Bn | 7.19 Bn | 256.31 Mn | - |
| 4 | Hinge Health | 5.15 Bn | 4.83 Bn | 154.23 Mn | - |
| 5 | Doximity | 3.75 Bn | 3.00 Bn | 125.97 Mn | - |
| 6 | 10x Genomics | 3.69 Bn | 3.15 Bn | 106.18 Mn | - |
| 7 | Waystar Holding | 3.61 Bn | 3.45 Bn | 268.04 Mn | - |
| 8 | Privia Health | 2.90 Bn | 2.54 Bn | 595.71 Mn | 646,000.00 |
| 9 | Omnicell | 1.72 Bn | 1.54 Bn | 140.36 Mn | - |
| 10 | Vsee Health | - | - | 1.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 31,980.00 |
| Dec 31, 2023 | 33,749.00 |
| Sep 30, 2023 | 12,465.00 |
| Jun 30, 2023 | -3,971.00 |
| Mar 31, 2023 | -4,767.00 |